Talis Biomedical Corporation
POLYNUCLEOTIDES FOR AMPLIFICATION AND DETECTION OF SARS-COV-2
Last updated:
Abstract:
Disclosed herein are primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of SARS-CoV-2 in test samples and/or to diagnose Covid-19. Specifically, the present disclosure describes primers and probes that bind to the N gene, ORF1ab, or E gene of SARS-CoV-2 coronavirus for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
Status:
Application
Type:
Utility
Filling date:
20 May 2021
Issue date:
4 Nov 2021